biotech

The Creation Of Biotech Startups: Evolution Not Revolution
The Creation Of Biotech Startups: Evolution Not Revolution
Forbes
biotech
startups
Flag link:
One health care startup at a time, this venture capitalist wants to harness the investing power of women
One health care startup at a time, this venture capitalist wants to harness the investing power of women
Stat
venture capital
biotech
startups
Women's Health
Flag link:
Analysts track doubling in number of private biotech rounds
Analysts track doubling in number of private biotech rounds
Fierce Biotech
biotech
IPOs
Flag link:
Top Scripps scientist and biotech co-founder makes an abrupt — and unexplained — exit
Top Scripps scientist and biotech co-founder makes an abrupt — and unexplained — exit
Endpoints
Scripps Research Institute
biotech
Synthorx
Flag link:
Alexandria seals $143M deal in Seattle's 'heart of the heart,' grabbing coveted land to build its biotech cluster
Alexandria seals $143M deal in Seattle's 'heart of the heart,' grabbing coveted land to build its biotech cluster
Endpoints
Seattle
biotech
Alexandria
Flag link:
Tactiva Therapeutics — A Biotech Startup Focusing on the Future of Immunotherapy
Tactiva Therapeutics — A Biotech Startup Focusing on the Future of Immunotherapy
Persimmon Development
Tactiva Therapeutics
startups
biotech
immunotherapy
Flag link:
The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
Yahoo/Benzinga
biotech
earnings
Immunic
Alkermes
Conatus
Aevi Genomic
Tricida
Curis
Ultragenyx
Leap Therapeutics
Cidara Therapeutics
Akcea
Spark Therapeutics
Eli Lilly
AnaptysBio
clinical trials
Flag link:
Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups
Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups
Endpoints
biotech
venture capital
Flag link:
Michael Becker, patient advocate and biotech exec, dies at 50
Michael Becker, patient advocate and biotech exec, dies at 50
BioCentury
Michael Becker
patients
biotech
HPV
entrepreneurs
Flag link:
Megadeals Enter Biotech Realm — And 3 Other Trends To Watch In 2019
Megadeals Enter Biotech Realm — And 3 Other Trends To Watch In 2019
Investors Business Daily
biotech
M&A
China
Flag link:
Trade tensions are impeding the flow of Chinese money to US biotechs — but how much?
Trade tensions are impeding the flow of Chinese money to US biotechs — but how much?
Endpoints
China
venture capital
biotech
trade
Flag link:
Commuting Can Become a Waiting Game in These Biotech Hubs
Commuting Can Become a Waiting Game in These Biotech Hubs
BioSpace
biotech
biotech hubs
commuting
Flag link:
Schrödinger hires ex-Eisai, Merck staff for push into clinic
Schrödinger hires ex-Eisai, Merck staff for push into clinic
Fierce Biotech
Schrödinger
R&D
Eisai
Merck
biotech
Flag link:
Chipscreen set to test Shanghai’s new innovation board
Chipscreen set to test Shanghai’s new innovation board
BioCentury
Chipscreen
biotech
Shanghai
innovation
Flag link:
#BIO2019: Taking the Pulse of Dealmakers: 2019 Outlook
#BIO2019: Taking the Pulse of Dealmakers: 2019 Outlook
BIOTechNow
biotech
M&A
Flag link:
Former GSK site to be redeveloped as WeWork-styled life sciences center
Former GSK site to be redeveloped as WeWork-styled life sciences center
Biopharma Dive
Philadelphia
R&D
biotech
GSK
Flag link:
Biotechs dive deeper into targeted cancer research, despite costs
Biotechs dive deeper into targeted cancer research, despite costs
Biopharma Dive
biotech
clinical trials
cancer
drug development
Flag link:
It Starts with One: Stephen Tang and the Future of Biotechnology in Philadelphia
It Starts with One: Stephen Tang and the Future of Biotechnology in Philadelphia
BIOTechNow
Philadelphia
Stephen Tang
biotech
Flag link:
US Crackdown On Foreign Biotech Investment Makes Us Poorer, Not Safer
US Crackdown On Foreign Biotech Investment Makes Us Poorer, Not Safer
Forbes
biotech
international investment
China
Flag link:
Ex-FDA commish Scott Gottlieb makes a quick jump back onto the money side of biotech
Ex-FDA commish Scott Gottlieb makes a quick jump back onto the money side of biotech
Endpoints
biotech
FDA
Scott Gottlieb
New Enterprise Associates
Flag link:

Pages